AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · IEX Real-Time Price · USD
2.790
-0.060 (-2.11%)
At close: Jul 19, 2024, 4:00 PM
2.730
-0.060 (-2.15%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
AN2 Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AN2 Therapeutics stock have an average target of 4.00, with a low estimate of 2.00 and a high estimate of 6.00. The average target predicts an increase of 43.37% from the current stock price of 2.79.
Analyst Consensus: Buy
* Price targets were last updated on May 16, 2024.
Analyst Ratings
The average analyst rating for ANTX stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 1 | 1 | 1 | 2 |
| Hold | 4 | 4 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Jul 3, 2024 |
| Evercore ISI Group | Evercore ISI Group | Hold Maintains $7 → $2 | Hold | Maintains | $7 → $2 | -28.32% | May 16, 2024 |
| JMP Securities | JMP Securities | Hold → Buy Upgrades $6 | Hold → Buy | Upgrades | $6 | +115.05% | Apr 2, 2024 |
| Oppenheimer | Oppenheimer | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 1, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $23 → $7 | Buy → Hold | Downgrades | $23 → $7 | +150.90% | Feb 13, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.47
from -2.74
EPS Next Year
-2.43
from -2.47
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 76.3M | 294.4M | 779.9M |
| Avg | n/a | n/a | 37.8M | 169.1M | 397.0M |
| Low | n/a | n/a | n/a | n/a | 34.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 679.4% | 361.2% |
| Avg | - | - | - | 347.7% | 134.8% |
| Low | - | - | - | - | -79.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.36 | -1.80 | -0.28 | 5.99 | 18.06 |
| Avg | -2.47 | -2.43 | -0.72 | 4.12 | 11.64 |
| Low | -2.64 | -2.67 | -1.32 | 2.33 | 5.52 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 338.3% |
| Avg | - | - | - | - | 182.5% |
| Low | - | - | - | - | 33.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.